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Abstract PSD-95/SAP90, which binds to the C-terminus of 
NMDA receptor and Shaker-type potassium channel, is one of 
the major postsynaptic density proteins. Recently, novel classes 
of proteins interacting with the guanylate kinase domain of PSD-
95 have been identified, guanylate kinase-associated protein 
(GKAP) and SAP907PSD-95-associated proteins (SAPAPs). 
Here we report the isolation of new isoforms of PSD-95 binding 
protein (GKAP/SAPAP1) using the yeast two-hybrid system. 
The isolated protein directly interacts with the guanylate kinase 
domain of PSD-95. Northern blot analyses revealed that the 
expression of these isoforms containing distinct N-terminal 
sequences is differentially regulated during brain development. 
The present findings suggest that each isoform of the PSD-95 
binding protein is differentially expressed in a development-
dependent manner and may be involved in the complex formation 
of PSD-95 and channel/receptors at the postsynaptic density. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Postsynaptic density (PSD) is a unique synaptic structure 
underlying the postsynaptic membrane of excitatory nerve 
synapses. Morphological analyses revealed a specialization 
of the PSD during postnatal development [1,2]. Several com-
ponents have been identified in the P S D : for example, actin, 
spectrin (calspectin or fodrin), MAP2, tubulin, and Ca 2 + / 
calmodulin-dependent protein kinase II [3-6]. However, the 
overall components and the molecular organization of PSD 
remain unknown [3-8]. Several P D Z domain-containing pro-
teins such as chapsyn-110, PSD-95/SAP90, SAP97, and 
SAP102 have been identified in the pre- and postsynaptic sites 
[9-13]. They have repeating P D Z domains, an Src homology 
domain 3 (SH3), and/or a domain that has homology with a 
yeast guanylate kinase (GK) in order from the N-terminus to 
the C-terminus [14,15]. PSD-95/SAP90 has been identified as 
one of the abundant proteins in the PSD fraction [10]. It binds 
to N M D A receptor and Shaker-type potassium channel 
through the P D Z domain [16-18]. Kim et al. have demon-
strated the clustering of N M D A receptor or potassium chan-
nel mediated by the P D Z domain of PSD-95 [9,17]. In con-
trast, there have been few reports regarding the functional role 
of the C-terminal SH3 or G K domain of PSD-95. To reveal 
the molecular organization of the PSD, using the yeast two-
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hybrid system, we searched for proteins interacting with the 
C-terminal side of PSD-95. During the course of our study, 
the isolation of new classes of proteins which interact with the 
G K domain of PSD-95 has been reported by two groups, the 
so called guanylate kinase-associated protein (GKAP) and 
SAP90/PSD-95-associated proteins (SAPAPs) [19,20]. We 
also independently isolated several c D N A clones of PSD-95 
binding protein which proved to be isoforms of GKAP/SA-
PAP1 by sequence analysis. These isoforms have unique se-
quence variants at the N-terminus. Nor thern blot analyses 
using specific probes for each N-terminal sequence revealed 
that these isoforms show different expressions during develop-
ment of rat brain. These findings suggest that the expression 
of these isoforms is differentially regulated at a transcriptional 
level during brain development. 
2. Materials and methods 
2.1. Yeast two-hybrid system 
The yeast two-hybrid system for the isolation of PSD-95 binding 
proteins was employed according to the method described previously 
[21,22]. The C-terminal 340 amino acids (residues 385-724) of rat 
PSD-95 were obtained by polymerase chain reaction (PCR) and sub-
cloned in frame into yeast expression vector pAS2-l, GAL4 binding 
domain vector (Clontech, USA) for bait construction. This bait vector 
was transformed into yeast strain Y-190 harboring the reporter gene 
HIS3 and lacZ. The bait strain was further transformed with a rat 
brain cDNA library constructed in pGADIO, GAL4 activation do-
main vector (Clontech). Positive clones growing on synthetic dropout 
—tryptophan/—leucine/—histidine plates containing 25 mM of 3-ami-
no-l,2,4-triazole were confirmed by (3-galactosidase filter assay, as 
described previously [21,22], 
2.2. 5' RACE and 3' RACE 
We performed 5' rapid amplification of cDNA ends (5' RACE) and 
3' RACE as described elsewhere [23]. We carried out PCR between 
the 5' and 3' sequences obtained by 5' and 3' RACE. The amplified 
fragments and the obtained clone by the yeast two-hybrid system were 
subcloned into pBluescript SK~ (Stratagene, USA) and sequenced. 
2.3. In vitro binding assay 
The full-length coding region of the PSD-95 binding protein 
(clone2-2A, shown in Fig. 1) was subcloned in frame into pQE30, 
hexahistidine (6 X His)-tagged fusion vector (Qiagen, USA). The rat 
PSD-95 C-terminus (residues 394-724), the SH3 domain with the 
flanking region (residues 394-533), and the GK domain (residues 
534-724) were obtained by PCR and subcloned in frame into 
pGEX-3X to produce glutathione S-transferase (GST)-tagged fusion 
proteins (Pharmacia, Sweden). The 6XHis fusion proteins and the 
GST fusion proteins were purified by Ni-NTA resin (Qiagen) and 
glutathione-coupled Sepharose 4B (Pharmacia), respectively. In over-
lay binding assay, the 6 X His-tagged fusion protein of clone2-2A was 
separated by SDS-PAGE, transferred to nitrocellulose membrane 
(Schleicher&Schuell, Germany), and probed by GST fusion proteins 
after blocking with Block Ace (Yukijirushi, Japan). The probes bound 
to the 6 X His-tagged protein were visualized by anti-GST polyclonal 
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antibodies (produced in our laboratory) and horseradish peroxidase 
H-conjugated anti-rabbit IgG (Promega, USA). 
2.4. Northern blot analysis 
Total RNAs were extracted from adult rat tissues using Isogene 
RNA extraction kit (Nippon Gene, Japan). To analyze expressional 
change of the PSD-95 binding protein and PSD-95 mRNAs during 
brain development, total RNAs were extracted from rat whole brains 
at indicated developmental stages. 10 ug of total RNAs was separated 
on 1.0% agarose formaldehyde denaturing gels, and then transferred 
to nylon membranes (GeneScreen, USA). The fragment which was 
present in clone2-2A-D and SAPAP1 in common (nucleotide posi-
tions 1564-2176 of GenBank AB003594) was 32P-labelled by the ran-
dom priming method and used as a probe (Fig. 3C, common probe). 
For Northern blot analysis of PSD-95, PSD-95 cDNA fragment ex-
panding from nucleotide positions 1212-2229 (GenBank M96853) was 
labelled by the random priming method. As a specific probe for 
clone2-2A, B, and C, a 145 bp cDNA fragment (nucleotide positions 
1-145 of GenBank AB003594) was 32P-labelled using a specific anti-
sense oligonucleotide (5'-CTGTCCATTCATCCTGGGGAAC-3') 
(Fig. 3C, probe I). As a specific probe for clone2-2D, a 451 bp 
cDNA fragment (nucleotide positions 31—481 of GenBank 
AB005146) was prepared in the same way (Fig. 3E, probe II). For 
SAPAPl-specific probe [20], a SAPAP1 cDNA fragment (nucleotide 
positions 272-1270 of GenBank U67137) was obtained by PCR and 
32P-labelled by the random priming method (Fig. 3G, probe III). To 
normalize the applied RNAs, ribosomal RNAs were stained with 
0.02% methylene blue. 
3. Results and discussion 
3.1. Isolation of PSD-95 binding protein 
For the isolation of proteins that interact with the C-termi-
nus of PSD-95, the yeast two-hybrid system was introduced to 
screen a rat brain cDNA library using a bait consisting of the 
C-terminal 340 amino acids (residues 385-724) of rat PSD-95. 
6.0 XlO6 independent colonies were screened, and a single 
clone, clone2-2, carrying a 1260 bp sequence was isolated 
(Fig. 1). We then applied the 5' and 3' RACE methods to 
obtain the full-length coding sequence of clone2-2. As a result, 
we obtained four full-length coding sequences, clone2-2A-D, 
shown in Fig. 1. Sequence analysis of clone2-2A reveals an 
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Fig. 1. Schematic structures of isolated clones as compared with 
GKAP and SAPAPI. The common sequence in all isoforms is de-
picted as a white bar. The specific N-terminal sequence shared by 
clones2-2A, B, C and GKAP is indicated as shaded boxes. The 
black box and the hatched boxes at the N-terminus indicate the spe-
cific N-terminal sequences in clone2-2D and SAPAPI, respectively. 
Hatched boxes in the middle portion refer to the two types of in-
serted sequence. The amino acid sequences of these boxes are also 
shown. Clone2-2B has a deletion of two amino acids (amino acid 
positions 27 and 28 of GenBank U67987) around the N-terminal 
splicing site. Clone2-2, isolated by the two-hybrid system, is indi-
cated as a black bar at the top in the corresponding position. 
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Fig. 2. In vitro interaction between PSD-95 and the PSD-95 binding 
protein. The direct interaction between PSD-95 and the PSD-95 
binding protein was examined using the gel overlay assay. The 
6xHis-tagged clone2-2A fusion protein separated by SDS-PAGE is 
probed with GST, GST-SH3+GK, GST-SH3, or GST-GK. Molecu-
lar size markers are indicated on the left in kilodaltons. The arrow-
head indicates the position of the 6xHis-tagged clone2-2A. The 
SDS gel loading the same sample was stained with Coomassie blue 
and is shown at the bottom. 
open reading frame that encodes a sequence of 694 amino 
acids with a calculated MI of 77 000. There are presumably 
three distinct splicing variants at the N-terminus of the iso-
lated clone, clones2-2A and C, clone2-2B, and clone2-2D. A 
two-amino acid deletion around the N-terminal splicing site 
was detected in two clones of five clone2-2A by the 5' RACE 
(clone2-2B). Since the reading frame is not disrupted, this 
deleted protein seems to be one of the isoforms of the PSD-
95 binding protein. The nucleotide sequence of clone2-2B has 
been submitted to the GenBank Data Bank with accession 
number AB003594. In addition to these N-terminal variants, 
a 10-amino acid deletion was also observed in the middle 
portion of this molecule (clone2-2C). This deletion most likely 
represents an alternative splicing based on its in-frame se-
quence. In comparison with data base entries, the four clones 
obtained are thought to originate from the same gene with 
GKAP and SAPAPI because they contain identical sequences 
except for the N-terminus and the central region, but clones2-
2B and D are novel isoforms that have not yet been reported. 
The N-terminal sequence of clones2-2A-C is essentially the 
same with that of GKAP. Clone2-2D is therefore thought 
to be the rat homologue of human GKAP. Up to this time, 
four sequence variants have been identified at the N-terminus 
of the PSD-95 binding protein (Fig. 1). 
3.2. In vitro binding assay 
We further examined the interaction between the obtained 
clone2-2 and PSD-95 using the yeast two-hybrid system. They 
bound each other even when the inserts were exchanged be-
tween the binding domain vector and the activation domain 
vector. Furthermore, clone2-2 specifically bound to the bait 
consisting of the GK domain but not to that of the SH3 
domain of PSD-95 in the yeast two-hybrid system (data not 
shown). We performed a gel overlay assay to confirm the 
direct interaction between the GK domain of PSD-95 and 
the PSD-95 binding protein in another system. As shown in 
Fig. 2, the 6 X His-tagged clone2-2A fusion protein was sepa-
rated by SDS-PAGE and transferred to nitrocellulose mem-
brane, followed by overlay assay probed with GST, GST-
tagged PSD-95 C-terminus (GST-SH3+GK), GST-tagged 
SH3 domain with the flanking region (GST-SH3), or GST-
tagged GK domain (GST-GK). The 6 X His-tagged clone2-2A 
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Fig. 3. Expression of the PSD-95 binding protein mRNAs. A: Tissue distribution of the PSD-95 binding protein mRNAs. Total RNAs from 
adult rat tissues were hybridized with the 32P-labelled common probe shown in C. The lanes indicate: 1, brain; 2, testis; 3, lung; 4, heart; 5, in-
testine; 6, colon; 7, liver; 8, spleen; 9, kidney. The sizes of the transcripts calculated from the mobility are indicated on the left side in kilo-
bases. B: Expressional changes of the PSD-95 binding protein mRNAs during brain development were revealed by a common probe. Total 
RNAs from rat whole brains at indicated stages were analyzed. Lane 1, embryonic day 18; 2, postnatal day 0; 3, day 5; 4, day 15; 5, day 30; 
6, 6 weeks. To compare the expression pattern of PSD-95, the Northern blot of PSD-95 is shown in the middle panel. 28S RNAs for the 
standardization are shown at the bottom. C, E, G: Schematic structures are essentially the same as in Fig. 1 and probes used in this figure are 
shown as bold black lines in the corresponding positions. D: Northern blot analysis using a clone2-2A-, B-, and C-specific sequence at the N-
terminus as a probe (probe I shown in C). F: Northern blot analysis using a clone2-2D-specific probe (probe II shown in E). H: Northern 
blot analysis using an SAP API -specific probe (probe III shown in F). Numbers of lanes indicated in D, F, and H are the same developmental 
days as in B. 
protein interacted with GST-SH3+GK and GST-GK, but not 
with GST or GST-SH3. This result is consistent with that of 
the two-hybrid system. Kim et al. have performed overlay 
filter assay and demonstrated the in vitro interaction between 
PSD-95 and GKAP [19]. We could confirm their results using 
the same method in spite of some differences in vector con-
structions and assay conditions. 
3.3. Expression of PSD-95 binding protein mRNAs 
We performed Northern blots to analyze the expression of 
the PSD-95 binding protein mRNAs regarding tissue distribu-
tion and brain development. Northern blots using a common 
probe revealed that the PSD-95 binding protein mRNAs were 
exclusively expressed in brain and testis, but not in any other 
tissues (Fig. 3A). In adult rat brain, the transcripts were at 
least composed of two major bands, 7.6 kb and 5.4 kb in size. 
We consider that both transcripts originate from the same 
gene encoding PSD-95 binding protein because several frag-
ments containing common sequences, and antisense sequences 
used as probes, showed the same results under high stringency 
conditions (data not shown). In the testis, the 3.9 kb tran-
script was dominant (Fig. 3A). The 7.6 kb and 5.4 kb tran-
scripts in the brain were differentially expressed during devel-
opment (Fig. 3B). The 7.6 kb transcript was rapidly expressed 
at birth and increased to reach a plateau by the adult stage. 
The 5.4 kb transcript was detected at birth and was gradually 
upregulated thereafter. To determine the expression patterns 
of various isoforms of the PSD-95 binding protein mRNAs in 
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the brain, we performed Northern blot analyses using specific 
probes for each N-terminal sequence variant. When the 145 
bp fragment representing clone2-2A, B, and C (probe I, 
shown in Fig. 3C) was used as a probe, major 5.4 kb and 
minor 7.6 kb transcripts were detected. Both transcripts ap-
peared at birth and were gradually upregulated during brain 
development (Fig. 3D). Using the 451 bp fragment represent-
ing clone2-2D (probe II, shown in Fig. 3E), only a 5.4 kb 
transcript was shown. It was first detected at postnatal day 
15, and gradually upregulated thereafter (Fig. 3F). The N-
terminal-specific sequence of SAP API as a probe (probe III, 
shown in Fig. 3G) showed only a 7.6 kb mRNA, which was 
gradually downregulated from birth to the adult stage (Fig. 
3H). These results indicate that the 5.4 kb mRNAs using a 
common probe are composed of transcripts of clones2-2A, B, 
C and clone2-2D, and the 7.6 kb mRNAs are transcripts 
combined with SAPAP1, clones2-2A, B, and C. The expres-
sion patterns of various isoforms during brain development, 
therefore, could be divided into two groups: the one is upre-
gulated (clones2-2A, B, C, and D) and the other is downregu-
lated (SAPAP1). On the other hand, PSD-95 mRNAs were 
composed of two bands, a major 3.5 kb and a minor 6.0 kb 
one (Fig. 3B). Cho et al. have reported that the former was 
expressed in both forebrain and cerebellum, and the latter was 
prominent in cerebellum [10]. The expression patterns of the 
5.4 kb mRNAs originating from clones2-2A-D were coordi-
nated with the major 3.5 kb mRNA of PSD-95 during devel-
opment (Fig. 3B). Consequently, the transcription of the PSD-
95 binding protein isoforms containing distinct N-terminal 
sequences might be differentially regulated in brain at different 
developmental stages. 
In this study, using the yeast two-hybrid system and sub-
sequent RACE methods, we identified several clones which 
directly interacted with the GK domain of PSD-95. Based 
on our results, these clones might be encoded by the same 
gene as GKAP/SAPAP1, but we provided additional splicing 
variants in the N-terminus. We also reported differential ex-
pression of isoforms of the PSD-95 binding protein mRNAs 
dependent on different transcriptional and splicing regulations 
during brain development. 
Although the precise function of this PSD-95 binding pro-
tein remains unknown, the interaction between NMDA recep-
tor/potassium channel, PSD-95, and a family of this protein 
may contribute to the molecular organization of the PSD. Our 
next purpose is to reveal the interaction between these com-
plexes and cytoskeletal proteins, especially the actin-based cy-
toskeleton, and to elucidate the functional and structural 
mechanisms which regulate their interactions in the PSD. 
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